JP Patent

JP6958860B2 — ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途

Assigned to Tohoku University NUC · Expires 2021-11-02 · 5y expired

What this patent protects

Patent listed against apomorphine-hydrochloride.

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP6958860B2
Jurisdiction: JP
Classification: —
Expires: 2021-11-02
Drug substance claim: No
Drug product claim: No
Assignee: Tohoku University NUC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.